NCT05398445 A Study Evaluating Rocatinlimab in Moderate-to-severe Atopic Dermatitis (ROCKET-IGNITE) Status COMPLETED Phase PHASE3
NCT05398263 Tezepelumab Efficacy and Safety in Reducing Oral Corticosteroid Use in Adults With Oral Corticosteroid Dependent Asthma Status TERMINATED Phase PHASE3
NCT05378529 A Cross-sectional Study of Lipoprotein(a) Levels in Patients With Documented History of Atherosclerotic Cardiovascular Disease (ASCVD) Status COMPLETED Phase NA
NCT05368103 Study of DAXDILIMAB for the Treatment of Moderate-to-Severe Alopecia Areata Status COMPLETED Phase PHASE2
NCT05361395 First-Line Tarlatamab in Combination With Carboplatin, Etoposide, and PD-L1 Inhibitor in Subjects With Extensive Stage Small Cell Lung Cancer (ES-SCLC) Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05360225 Testing of DNA Extracted From Tumor Tissue Biopsy Samples Using Therascreen KRAS RGQ PCR Kit Status COMPLETED Phase N/A
NCT05348187 Clinical Performance Study Protocol for Therascreen® KRAS RGQ PCR Kit Status COMPLETED Phase NA
NCT05347797 Clinical Study Testing DNA Extracted From Tumour Tissue Biopsy Samples, Using the Therascreen® KRAS RGQ PCR Kit Status COMPLETED Phase NA
NCT05327491 A Study in Healthy Volunteers to Compare the Pharmacokinetics of Sotorasib Administered as 1 or 2 Tablets Status COMPLETED Phase PHASE1
NCT05325866 A Study Evaluating Bemarituzumab in Solid Tumors With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression Status TERMINATED Phase PHASE1/PHASE2
NCT05323617 Efficacy of Romiplostim in Treatment of SAA in Adults Previously Untreated With or Refractory to Immunosuppressive Therapy Status WITHDRAWN Phase PHASE2
NCT05322577 A Study Evaluating Bemarituzumab in Combination With Other Anti-cancer Therapies in Subjects With Previously Untreated Advanced Gastric or Gastroesophageal Junction Cancer. Status TERMINATED Phase PHASE1/PHASE2
NCT05317078 A Phase 1 Safety, Tolerability, and Pharmacokinetics Study of AMG 794 With Claudin 6-positive Non-small Cell Lung Cancer, Epithelial Ovarian Cancer, and Other Malignant Solid Tumor Indications Status TERMINATED Phase PHASE1
NCT05284747 EVOLVE-MI: EVOLocumab Very Early After Myocardial Infarction Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT05267470 A Study of Bemarituzumab Monotherapy and Combination With Other Anti-cancer Therapy in SqNSCLC With FGFR2b Overexpression (FORTITUDE-201) Status TERMINATED Phase PHASE1
NCT05251038 Study of Sotorasib Combined With Chemotherapy for Second Line Treatment of Pancreas Cancer Status WITHDRAWN Phase PHASE1/PHASE2